ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $230M

      Shares

      1.42M

      % of Portfolio

      2.41%

      Average Buy Price

      $93

      Avg closing price
      Price range

      50 John W. Rogers Jr. Charles River Laboratories International Trades

      John W. Rogers Jr.'s position in Charles River Laboratories International is currently worth $230M. That's 2.41% of their equity portfolio (15th largest holding). The investor owns 2.86% of the outstanding Charles River Laboratories International stock. The first Charles River Laboratories International trade was made in Q1 2013. Since then John W. Rogers Jr. bought shares eighteen more times and sold shares on 31 occasions. The stake costed the investor $132M, netting the investor a gain of 74% so far.

      Avg closing price
      Price range
      Increased shares by 28.6% (+315k shares) Q2 2025
      Avg closing price $133.19
      Price range $99.75 - $151.89
      Increased shares by 3.1% (+33.4k shares) Q1 2025
      Avg closing price $167.66
      Price range $150.52 - $190.14
      Increased shares by 18.9% (+170k shares) Q4 2024
      Avg closing price $192.62
      Price range $178.58 - $220.69
      Sold 0.9% shares (-8.45k shares) Q3 2024
      Avg closing price $207.57
      Price range $187.96 - $245.29
      Sold 2.9% shares (-26.7k shares) Q2 2024
      Avg closing price $226.59
      Price range $206.39 - $268.73
      Sold 11.2% shares (-118k shares) Q1 2024
      Avg closing price $238.81
      Price range $203.52 - $273.43
      Sold 1.5% shares (-15.9k shares) Q4 2023
      Avg closing price $196.66
      Price range $164.52 - $238.84
      Increased shares by 1.8% (+18.8k shares) Q3 2023
      Avg closing price $205.30
      Price range $194.44 - $217.61
      Increased shares by 53.4% (+365k shares) Q2 2023
      Avg closing price $198.96
      Price range $183.71 - $210.25
      Increased shares by 7.1% (+45.3k shares) Q1 2023
      Avg closing price $226.63
      Price range $191.89 - $259.92
      Sold 2.0% shares (-12.7k shares) Q4 2022
      Avg closing price $218.37
      Price range $197.11 - $250.07
      Increased shares by 10.3% (+60.9k shares) Q3 2022
      Avg closing price $215.88
      Price range $182.44 - $250.54
      Increased shares by 181.1% (+380k shares) Q2 2022
      Avg closing price $244.35
      Price range $204.13 - $302.40
      Increased shares by 16.8% (+30.1k shares) Q1 2022
      Avg closing price $308.36
      Price range $255.51 - $362.11
      Sold 1.9% shares (-3.56k shares) Q4 2021
      Avg closing price $388.52
      Price range $351.38 - $448.68
      Sold 17.1% shares (-37.9k shares) Q3 2021
      Avg closing price $415.31
      Price range $372.64 - $458.30
      Sold 46.2% shares (-190k shares) Q2 2021
      Avg closing price $333.92
      Price range $294.17 - $371.65
      Sold 0.4% shares (-1.79k shares) Q1 2021
      Avg closing price $277.97
      Price range $249.67 - $299.48
      Sold 15.8% shares (-77.5k shares) Q4 2020
      Avg closing price $238.16
      Price range $222.00 - $252.62
      Sold 21.5% shares (-134k shares) Q3 2020
      Avg closing price $207.53
      Price range $175.56 - $226.45

      News about Charles River Laboratories International Inc. and John W. Rogers Jr.

      CHARLES RIVER 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Charles River Laboratories International, Inc. - CRL

      CHARLES RIVER 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Charles River Laboratories International, Inc. - CRL

      Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 18...

      Wallstreet:Online Wallstreet:Online, about 2 years ago
      CHARLES RIVER LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Charles River Laboratories International, Inc. - CRL

      CHARLES RIVER LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Charles River Laboratories International, Inc. - CRL

      NEW ORLEANS, May 26, 2023 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind ...

      PR Newswire PR Newswire, over 2 years ago
      CHARLES RIVER LABORATORIES SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against Charles River Laboratories International, Inc. - CRL

      CHARLES RIVER LABORATORIES SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against Charles River Laboratories International, Inc. - CRL

      NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (¡°KSF¡±) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors th...

      Business Wire Business Wire, over 2 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×